Clinical Trial Update: 11C Topotecan PET Imaging [EARLY_Phase 1]

View source ↗

Summary

A EARLY Phase 1 trial of 11C-labeled topotecan for PET imaging in lung and ovarian cancers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Ovarian Cancer

Drugs mentioned

• Topotecan (topotecan)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Lung Cancer, Metastatic Cancer | EARLY_Phase 1 | Status: TERMINATED